Contact us for a free case consultation 866-281-8659

Living Safer Magazine

Check out the latest issue of D’Amore Law Group’s Living Safer magazine!

Categories

Archive for the ‘Medicines’ Category

$3 million settlement over suicide of man on antidepressants
Friday, September 15th, 2017

In 2010, Stewart Dolin began taking the antidepressant paroxetine, the generic form of Paxil. Five days after he started the prescription, the 57-year-old Chicago lawyer threw himself in front of a train and committed suicide. His wife, Wendy Dolin, believes that her husband suffered from akathisia, a state of acute psychological and physical agitation, which […]

Prenatal Exposure to Valproate Increases Risk of Autism
Wednesday, December 21st, 2011

Valproate is a a chemical compound used as an anticonvulsant in the treatment of epilepsy. A presentation recently delivered at the annual meeting of the American Epilepsy Society advised that children born to mothers with epilepsy treated with valproate during pregnancy are at an increased risk for autism. The study included 655,691 children born to […]

Accidental Poisoning Cases Rise in U.S.
Monday, October 31st, 2011

30 children die every year in the U.S. from accidental medicine poisoning.  The alarming rise of cases of child poisoning was highlighted in recent report by Portland’s KGW and Seattle’s KING5 news, which tells the story of a doctor whose toddler was poisoned by pills she mistook for candy while trick-or-treating in his office last […]

Electronic Prescriptions As Likely to Contain Errors as Handwritten Ones
Tuesday, July 19th, 2011

According to a paper recently published in the Journal of American Medical Information Association, by Dr. Karen Nanji of Massachusetts General Hospital in Boston, more than 10% of electronic prescriptions contain an error, which means that prescriptions sent electronically are just as likely to contain mistakes as handwritten ones. The researchers analyzed 3,850 computer-generated prescriptions […]

Diabetes Drug Actos May Increase Risk of Cancer
Friday, June 17th, 2011

Actos a prescription drug of the class thiazolidinedione that is used to treat type 2 diabetes. This week, the FDA announced that patients taking Actos for more than a year may have an increased risk of bladder cancer. The FDA's announcement is based on its review of data from a planned five-year interim analysis of […]

FDA Recommends Reducing Dosage of Popular Cholesterol-Lowering Drug Simvastatin
Monday, June 13th, 2011

Simvastatin is a prescription drug used to control elevated cholesterol. Last week, the FDA recommended that doctor not start patients on an 80 mg dose of simvastatin – the highest approved dose of the drug — because of the risk of a condition known as myopathy, characterized by unexplained muscle weakness or pain. The FDA further […]

Regulators Question Safety of Growth Hormone After Study Shows Increased Risk of Death Among Adults Treated With Hormone as Children
Wednesday, January 12th, 2011

As reported on MedPage Today, in early December, the European Medicines Agency (EMA) (the European Union's equivalent of the FDA) announced it will investigate the safety of growth hormone (known generically as somatropin) used to treat growth hormone deficiency and short stature in children.  The review is based on data from a long-term study of […]

FDA Orders Painkillers Darvon and Darvocet Pulled from Market
Wednesday, November 24th, 2010

The FDA has ordered manufacturers of Darvon and Darvocet (painkillers containing propoxyphene) to stop selling the drugs after receiving new clinical data showing that the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities. As a result of these data, combined with other information, including new epidemiological data, the agency […]

Lipitor Recall
Tuesday, October 12th, 2010

Pfizer has recalled specific bottles of LIPITOR (40 mg only) due to a small number of reports of an uncharacteristic odor related to the bottles in which LIPITOR is packaged. The odor is not likely to cause adverse health consequences in patients taking LIPITOR. But patients are advised that if they take LIPITOR 40 mg […]

Counterfeit Tamiflu Sold By Internet-Based Pharmacies is Dangerous to Patients Allergic to Penicillin
Monday, June 21st, 2010

Last week, the FDA notified consumers and healthcare professionals about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu’s active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. Patients who are allergic to penicillin products […]